Associated Papers
A quantitative, Bayesian-informed approach to gene-specific variant classification: Updated Expert Panel recommendations improve classification of TP53 germline variants for Li-Fraumeni syndrome.
Fortuno C et al.
Genome Medicine, 2025
41126324 (PubMed )
Supplement: 13073_2025_1536_MOESM2_ESM.xlsx › Table_S2
TP53_PROF: a machine learning model to predict impact of missense mutations in TP53.
Ben-Cohen G et al.
Briefings in Bioinformatics, 2022
35043155 (PubMed )
Supplement: supplementary_table_s1_bbab524.xlsx › S1B._Negative_Set
The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3.
Vaughan CA et al.
Nature Communications, 2021
Translational Control in p53 Expression: The Role of 5'-Terminal Region of p53 mRNA.
Swiatkowska A et al.
International Journal of Molecular Sciences, 2019
Structural and sequential context of p53: A review of experimental and theoretical evidence.
Saha T et al.
Progress in Biophysics and Molecular Biology, 2015
Mutant TP53 posttranslational modifications: challenges and opportunities.
Nguyen TA et al.
Human Mutation, 2014
ATM/ATR checkpoint activation downregulates CDC25C to prevent mitotic entry with uncapped telomeres.
Thanasoula M et al.
The Embo Journal, 2012
Study of MDM2 binding to p53-analogues: affinity, helicity, and applicability to drug design.
Kalid O et al.
Journal of Chemical Information and Modeling, 2009
Defective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23.
MacPherson D et al.
The Embo Journal, 2004
Select a paper to view details